<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_ZJU-China_Assessment_html"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:ZJU-China/Assessment.html">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:ZJU-China/Assessment.html&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:ZJU-China/Assessment.html&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:ZJU-China/Assessment.html&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:ZJU-China/Assessment.html" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:ZJU-China/Assessment.html</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2011.igem.org</H3><P><TITLE>Biotech Industry Funding Assessment</TITLE></P><DIV class="global"><DIV class="header"><DIV class="nav"><UL id="topnav"><LI><A id="P_Home" href="https://2011.igem.org/Team:ZJU-China/index.html">Home</A></LI><LI><A id="P_Project" href="https://2011.igem.org/Team:ZJU-China/Project.html">Project</A></LI><LI><A id="P_Team" href="https://2011.igem.org/Team:ZJU-China/Team.html">Team</A></LI><LI><A id="P_Notebook" href="https://2011.igem.org/Team:ZJU-China/Notebook.html">Notebook</A></LI><LI><A id="P_HumanPractice" href="https://2011.igem.org/Team:ZJU-China/Humanpractice.html">HumanPractice</A></LI></UL></DIV></DIV><DIV id="contentwrapper"><DIV class="main"><DIV class="leftulcontainer" id="purple"><DIV id="leftul" class="leftul"><DIV id="accordion"><H4>Overview</H4><DIV class="pane" style="height: auto"><A href="https://2011.igem.org/Team:ZJU-China/Humanpractice.html">Overview</A></DIV><H4>Safety</H4><DIV class="pane" style="height: auto"><A href="https://2011.igem.org/Team:ZJU-China/Safety.html">Safety</A></DIV><H4>Originality</H4><DIV class="pane" style="height: auto"><A href="https://2011.igem.org/Team:ZJU-China/App.html">iPhone App</A><A href="https://2011.igem.org/Team:ZJU-China/Novel.html">Novel</A></DIV><H4 class="current" style="font-size: 20px;">Funding Guide</H4><DIV class="pane" style="display: block; height: auto"><A href="https://2011.igem.org/Team:ZJU-China/Fundingreport.html">Funding Report</A><A href="https://2011.igem.org/Team:ZJU-China/Assessment.html">Assessment</A><A href="https://2011.igem.org/Team:ZJU-China/Manual.html">Manual</A></DIV><H4><A href="https://2011.igem.org/Team:ZJU-China/SBC.html">SBC</A></H4><DIV class="pane" style="height: auto"><A href="https://2011.igem.org/Team:ZJU-China/SBC.html">SBC</A></DIV></DIV></DIV></DIV><DIV class="rightcontainer"><DIV id="styleA" class="frame"><DIV id="purple"><H1>Biotech Industry Funding Assessment</H1><DIV id="framecontent"><DIV class="frame" id="guide3"><P>In order to have a brief understanding of the funding conditions
of teams from China, we distributed a survey concerning their funding
this year. In this survey, we mentioned several questions, such as
'where they got the funding', 'how much they have got', 'materials they
need to apply for funding', etc. We got several replies from
Fudan-Shanghai, SJTU-BioX-Shanghai, Tsinghua, etc. According to their
replies, we have found an interesting phenomenon. Most of iGEM teams
depend on the support of related departments of their school as well as
the College of Biological Science. Only a few teams have won funding
from biotechnology companies, such as SJTU-BioX-Shanghai. Even though
they have got support from Merck and GeneScript. Only Merck promises to
offer cash support, while GeneScript offers discounts of reagents.
However, teams from Europe earn major funding support from biotech
companies. For example, Imperial College London has earned support from
welcometrust, eurofins,NEW ENGLAND BioLabs and QIAGEN. Paris Bettencourt
has won support from Thermo, Invitrogen, Eurogentec, MINES ParisTech,
geneious,lif technologies, GATC, ROTH and so on.</P><P>The above phenomenon leads us into investigating the current
situation of Chinese biotech firms and R&amp;D (research and development).
Although Australia, Korea, Japan, and China stand out in terms of
biotech company number, sheer number is not an appropriate indication of
the industry's performance level (Figure 1). The R&amp;D expenditure of
China is far lower than that of USA (Figure 2). It reveals the limited
investment in scientific research and development in China's biotech
companies. Special regulation of investment in China more or less plays
a significance role in this problem. There has not been an incentive to
promote biotech companies or biotech industry to invest in new fields,
such as synthetic biology. Besides, their lack of knowledge of synthetic
biology has led to their unwillingness to invest in the research of this
field.</P><DIV class="frame" id="pic"><P style="text-align: center" align="center"><I>Figure 1</I><I>Source: Primary Interviews with Local Government Agencies.</I></P></DIV><DIV class="frame" id="pic"><P align="center" style="text-align: center"><I>Figure 2</I><I>R&amp;D expenditure in 2001 – 2003 (in billion USD).
 Source: OECD's Science and Technology Statistical Compendium 2004</I></P></DIV><P>According to statistics shown in Figure 3, biotech funding of the
world was up 46% to $36.2 billion in 2010 from $25.8 billion in 2009.
This obvious trend reveals that biotechnology has become an increasingly
hot spot.</P><P align="center" style="text-align: center"><I>Figure 3</I><I>Biotech funding was up 46% to $36.2 billion in 2010
from $25.8 billion in 2009.</I><I>Sources: BCIQ BioCentury Online Intelligence. Partnership figures
from Burrill &amp; Co. and Deloitte Recap are for deals involving a US
company. BioCentury makes updates to its financing data on an ongoing
basis.</I></P><DIV class="links"><A href="#top2">Top | </A><A href="#guide1">A
Funding Report for iGEM Teams </A><A href="#guide2"> | Funding Manual </A></DIV></DIV></DIV><DIV style="display: none" class="frame" id="rightnav"><DIV class="bgcolors" id="round"><P><A name="jumptop" id="bb">  Biobrick Group </A>|<A id="bf"> Biofilm Group  </A></P></DIV></DIV></DIV><DIV class="links"><A href="#top2">Top</A></DIV></DIV></DIV></DIV><DIV class="footer" id="footer"><A href="https://2011.igem.org/">
iGem 2011 Home Page</A><A href="http://ung.igem.org/Special:Upload/">
Upload Files</A><A href="https://2011.igem.org/wiki/index.php?title=Template:Zjucss_main&amp;action=edit">Edit
CSS</A><A href="http://ung.igem.org/Team_Wikis?year=2011"> Team Wikis</A><A href="mailto:zjuigem@gmail.com?"><STRONG>Contact Us</STRONG></A></DIV></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2011.igem.org/Team:ZJU-China/Assessment.html">http://2011.igem.org/Team:ZJU-China/Assessment.html</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:ZJU-China/Assessment.html" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:ZJU-China/Assessment.html" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:ZJU-China/Assessment.html&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:ZJU-China/Assessment.html&amp;oldid=254686" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2011.igem.org:Privacy_policy" title="2011.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2011.igem.org:General_disclaimer" title="2011.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>